I agree. Theses are some interesting questions. Many on this board would love to see an 8 dollar BO, subsequent to BTD and Adjunct approval, with strong data showing promise to Mono approval down the road. However, the disparity between 32% and 70% on the last BP BO's, at the very least needs careful assessment and evaluation as to CYDY's valuation in a BP BO scenario!